Not all people with CLL call for therapy. Despite all current improvements, the iwCLL even now recommends watchful observation for patients with asymptomatic condition.86 This suggestion is predicated on not less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Lengkapi formulir pendaftaran https://williams976cnz8.hamachiwiki.com/user